ASCO Guidelines for Systemic Treatment of Thyroid Cancer
ASCO has updated its systemic treatment guidelines for thyroid cancer, refining the use of kinase inhibitors and targeted therapies for radioiodine-refractory differentiated thyroid cancer and medullary thyroid cancer. These updates ... Read More